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Surgical Threshold for Bicuspid
Aortic Valve–Associated Aortopathy
Does the Phenotype Matter?
We read with great interest the paper by Hardikar and Marwick (1)
published in a recent issue of iJACC. The authors should be
congratulated for their efforts to address the controversial issue of
bicuspid aortic valve (BAV)–associated aortopathy in their current
meta-analysis. This report is based on a systematic review of the
published literature onBAVaortopathy,with a special focus on aortic-
related events during long-term follow-up. The most important
ﬁnding of thismeta-analysis is the very low risk of adverse aortic events
in patients with BAV disease, which is in contrast to the widespread
perception that exists in the cardiovasculardand in particular the
cardiac surgerydcommunity. Indeed, some have even incorrectly
equated this risk with that observed in patients with connective tissue
disorders (e.g., Marfan syndrome). Hardikar and Marwick (1) were
able to identify BAV patients that were at higher risk of aortic events,
however, according to patients’ age and clinical setting.
The major limitation of the aforementioned meta-analysis is the
heterogeneity of the published literature on BAV-associated aortic
disease. Such heterogeneity was partially addressed by means of
stratiﬁcation by stage of BAV disease (i.e., nonoperated vs. post-
operative BAV patients). However, major heterogeneity also exists
within the post-operative patients, as demonstrated by the highly
signiﬁcant I2 statistic (1). In our experience, this phenomenon may
be explained by the fact that different forms of BAV disease (so-
called BAV phenotypes) are frequently mixed together in published
reports (2). The 2 distinct clinical entities of BAV disease, namely,
BAV in patients presenting with predominant aortic valve stenosis
and dilation of the supra-coronary aorta (i.e., BAV stenosis
phenotype), and BAV in patients presenting with predominant
aortic insufﬁciency and dilation of the proximal aortic root (i.e.,
BAV root phenotype), are characterized by major differences in the
patterns and the prognosis of associated aortopathy (3,4). However,
very few published studies to date have separately analyzed these 2
distinct patient subgroups.
Hardikar and Marwick (1) used the age of BAV patients as an
additional clinical variable to stratify the outcomes of BAV-
associated aortopathy. However, age may also be interpreted as an
indirect marker of the different BAV phenotypes. Evidence of this
can be found in the fact that BAV patients who required aortic root
surgery for aortic regurgitation were in the 5th decade of life,
whereas patients undergoing isolated aortic valve replacement for
BAV stenosis were in their 6th decade. Such ﬁndings are also in linewith previous reports showing that aortic root dilation with resultant
aortic valve insufﬁciency (i.e., root phenotype) is predominantly
found in young, male BAV patients and is associated with a genetic
form of BAV-associated aortopathy (3,4).
The ﬁnding from Hardikar and Marwick (1) that aortic di-
mensions progress more rapidly with increasing age of BAV patients
may be somewhat misleading and should be interpreted with a
caution. The proposed correlation between the rate of aortic
enlargement and increasing age may be explained by the fact that the
2 referenced reports by La Canna et al. (5) and Davies et al. (6)
included patients with dilated BAV aortas only. It is generally
accepted that diameters of already dilated aortas progress more
rapidly; this, rather than just patient age, may account for the
accelerated growth of the proximal aorta observed in these studies.
The annual growth rate of aortic dimensions in distinct clinical
phenotypes (i.e., BAV stenosis vs. root phenotype) would be of great
clinical value and should be a focus of future studies.
With the literature that is currently available, it is very difﬁcult to
accurately deﬁne surgical thresholds for BAV-associated aortopathy,
because most of the published studies consist of mixed BAV
phenotype cohorts and different stages of BAV disease. We strongly
recommend a more homogeneous phenotype-speciﬁc reporting of
outcomes in BAV disease in future studies.
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REPLY : Surgical Threshold for Bicuspid Aortic
Valve–Associated Aortopathy: Does the Phenotype Matter?
We would like to thank Drs. Girdauskas and Borger for their
interest and comments regarding our paper (1). We also concur
regarding the main message of the meta-analysis, which is that
aortopathy associated with bicuspid aortic valve has very low
adverse event ratesdcontrary to the perception that this disease is
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319analogous to connective tissue disorders. This main ﬁnding is not
compromised by the heterogeneity of the literature.
The signiﬁcant heterogeneity in the literature is not restricted to
aortic stenosis and regurgitation, but also involves bicuspid aortic
valve morphologies, as well as the nature of the underlying tissue.
Indeed, we found that aortic regurgitationwas reported in an older age
groupdhad we focused on aortic valve repair publications, we would
have an entirely regurgitant population subset. Similarly, hadwe taken
a subgroup of publications from younger age groups, we would have
had a stenosis-predominant subset. Only a few authors have looked at
stenosis only (2), and hence, it was difﬁcult to compare these subsets
without the heterogeneity. An individual patient meta-analysis would
overcome the dependence of standard meta-analysis on the case-mix
of the original data, but the performance of this would require more
effective data archiving than is the current practice.
We agree that the relationship of age with aortic diameter could
be confounded by other factors (3,4). However, as those factors also
change with age, we thought that age might be a reasonable marker
to increase the clinician’s alertness. We hope that once we have
sufﬁcient longitudinal data from registry studies, these relationships
could be analyzed with more accuracy.
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Figure 1. Thirty-Day Follow-Up of Renal Function After TAVR
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Intracardiac Echo and Reduced
Radiocontrast Requirements
During TAVR
Acute kidney injury (AKI) is an independent predictor of mor-
tality after transcatheter aortic valve replacement (TAVR) (1,2)
and can be curbed by signiﬁcantly reducing the amount
of contrast agent (3). Intracardiac echocardiography (ICE) ap-
pears to match the TAVR workﬂow (4), provides the highest
image resolution, and requires only local anesthesia. It is hy-
pothesized that: 1) ICE is capable of effectively guiding TAVR,
reducing the radiocontrast agent requirements; 2) low-contrast
TAVR can minimize the risk of AKI; and 3) this strategy is
safe and can improve the outcome of TAVR.
Sixty consecutive patients underwent transfemoral or transapical
TAVR. In all patients, Edwards Sapien Transcatheter Heart Valves
(Edwards Lifesciences, Irvine, California) were implanted. Subjects
were randomized in a ratio of 1:1. In group 1, angiography served as
the primary and ICE as the complementary guiding tool. In group
2, TAVR was primarily guided by ICE and complemented by
angiography at the beginning of the procedure. If needed, angiog-
raphy was repeated after valve deployment. Longitudinal views (4)
served as primary ICE views and after deployment, short-axis
views of the prosthetic valve were obtained (Online Video 1). In
group 2, a pigtail catheter advanced into the noncoronary cusp
identiﬁed the level of the valvular annulus. Repeat angiography was
performed as needed only in group 1. AKI was graded as proposed
by the Valve Academic Research Consortium (5).B
zp ¼ 0.27, xp ¼ 0.02, kp ¼ 0.01, and mean D ¼ 0.34 mg/dl (95% conﬁdence
p differences on day 30: *p ¼ 0.21, yp ¼ 0.23, zp ¼ 0.18, xp ¼ 0.01, kp ¼ 0.03, and
stments for multiple comparisons were made. Please see Online Videos 1 and 2.
